Results 181 to 190 of about 112,758 (355)

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection [PDF]

, 2016
Aksoy, Alanen, Ascherio, Ayatollahi, Banez, Basch, Bergh, Berrington de Gonzalez, Borgermann, Bosch, Carter, Catalona, Chen, Elgamal, Fan, Fedewa, Grinstein, Hasui, Heidenreich, Joshi, Kadayifci, Kadayifci, Kilic, Krystyna, Kuller, Kutok, Lilja, Luzuriaga, Malavaud, Mandel, Moyer, Olsson, Oremek, Rickinson, Rubertone, Sfanos, Silverberg, Sindhwani, Smith, Stamey, Sutcliffe, Sutcliffe, Sutcliffe, Tchetgen, Whitaker, Whittemore, Wolf   +46 more
core   +2 more sources

Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas

, 2015
Johannes Doescher, Guido Piontek, Markus Wirth, Marcus Bettstetter, Jürgen Schlegel, Bernhard Haller, Gero Brockhoff, Rudolf Reiter, Anja Pickhard   +8 more
openalex   +2 more sources

Liver failure and Epstein-Barr virus infection. [PDF]

, 1988
N. Shaw, Jemma Evans
openalex   +1 more source

Stewardship of Molecular Diagnostics in Transplant Viral Infections

Transplant Infectious Disease, EarlyView.
ABSTRACT The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe infections in transplant environments. Therefore, guidelines tend to recommend broader microbial testing in
Scott Sugden, David Reynoso, Reema Mathew, Michael Loeffelholz   +3 more
wiley   +1 more source

Acyclovir‐Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series

Transplant Infectious Disease, EarlyView.
This retrospective case series of acyclovir‐resistant HSV infection in pediatric patients undergoing allogeneic HSCT discusses the clinical course, associated complications, and treatment, including side effects. We propose the first algorithm for investigating and managing acyclovir‐resistant HSV infections in pediatric HSCT recipients, highlighting ...
Jenna Nunn, Ahmed Ahmed, Srividhya Senthil, Oana Mirci‐Danicar, Denise Bonney, Claire Horgan, Omima Mustafa, Robert Wynn, Malcolm Guiver, Ramya Nataraj   +9 more
wiley   +1 more source

Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections. [PDF]

Front Microbiol, 2018
Górski A, Międzybrodzki R, Jończyk-Matysiak E, Weber-Dąbrowska B, Bagińska N, Borysowski J.   +5 more
europepmc   +1 more source

Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience. [PDF]

Ann Hematol, 2020
Zhou L, Gao ZY, Lu DP.
europepmc   +1 more source

Prevalence of Epstein-Barr Virus infection in a cohort of onco-hematologic paediatric patients

, 2023
Luna Colagrossi, Lorena Forquè Rodriguez, Luana Coltella, Stefania Ranno, Giulia Linardos, V. C. Di Maio, Leonarda Gentile, Simona Landi, Katia Yu La Rosa, Pietro Merli, Chiara Agrati, Federica Locatelli, Carlo Federico Perno, Cristina Russo   +13 more
openalex   +2 more sources

Donor–Recipient Epstein–Barr Virus Serostatus and Time‐Varying Risk of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients

Transplant Infectious Disease, EarlyView.
In a national US kidney transplant cohort, posttransplant lymphoproliferative disorder risk varied dynamically by donor–recipient Epstein–Barr virus serostatus. Donor‐positive/recipient‐negative recipients had the highest sustained risk, while donor‐negative/recipient‐negative recipients faced previously under‐recognized early risk, with PTLD strongly ...
Christie Rampersad, Seyed M. Hosseini‐Moghaddam, S. Joseph Kim   +2 more
wiley   +1 more source

Correction: Cytomegalovirus and Epstein-Barr virus infections among Jordanians: seroprevalence and associated factors. [PDF]

BMC Infect Dis
Kofahi HM, Swedan JF, Aljezawi M.
europepmc   +1 more source